Publications by authors named "Patrice Viens"

100Publications

The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017.

Eur J Cancer 2021 Jan 4;145:11-18. Epub 2021 Jan 4.

Institut Paoli Calmettes, SESSTIM UMR1252, Aix Marseille Univ, INSERM, IRD, Marseille, France. Electronic address:

View Article and Find Full Text PDF
January 2021

REBOUND "Trained to live again": The practice of great Olympic coaches improves and enhances the quality of life of cancer patients in remission after hematopoietic stem cell allogeneic transplantation.

Bone Marrow Transplant 2020 06 2;55(6):997-999. Epub 2020 Mar 2.

Department of Medical Oncology, Management Sport Cancer Laboratory EA4670, Aix-Marseille University and Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
June 2020

[E-health and "Cancer outside the hospital walls", Big Data and artificial intelligence].

Bull Cancer 2020 Jan 19;107(1):102-112. Epub 2019 Sep 19.

Institut Paoli-Calmettes, département d'oncologie médicale, 13009 Marseille, France; Aix-Marseille université, Centre de recherche en cancérologie de Marseille, Inserm U1068-CNRS U7258, 13009 Marseille, France.

View Article and Find Full Text PDF
January 2020

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers.

Cancers (Basel) 2019 Aug 13;11(8). Epub 2019 Aug 13.

Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Univ, CRCM, CNRS, INSERM, 13000 Marseille, France.

View Article and Find Full Text PDF
August 2019

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review.

Cancers (Basel) 2019 Jul 22;11(7). Epub 2019 Jul 22.

Department of Medical Oncology, Aix-Marseille University, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, 13009 Marseille, France.

View Article and Find Full Text PDF
July 2019

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.

Cancers (Basel) 2019 May 13;11(5). Epub 2019 May 13.

Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France.

View Article and Find Full Text PDF
May 2019

[Sport coaching for psychological and social recovery after hematological cancer: An innovative perspective].

Bull Cancer 2017 Oct 12;104(10):823-830. Epub 2017 Oct 12.

Centre de recherche en cancérologie (CRCM), Marseille, France; Aix-Marseille université (AMU), Marseille, France; Institut Paoli-Calmette, département d'oncologie, 232, boulevard Sainte-Marguerite, BP 156, 13273 Marseille cedex 9, France. Electronic address:

View Article and Find Full Text PDF
October 2017

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

Expert Rev Anticancer Ther 2017 07 25;17(7):593-606. Epub 2017 May 25.

a Department of Medical Oncology, Institut Paoli-Calmettes, Aix Marseille Univ , CNRS U7258, INSERM U1068, CRCM , Marseille , France.

View Article and Find Full Text PDF
July 2017

[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].

Bull Cancer 2017 Apr 16;104(4):332-343. Epub 2017 Feb 16.

Institut Paoli-Calmettes (IPC), département d'oncologie médicale, 232, boulevard de Sainte-Marguerite, 13009 Marseille cedex 9, France; Centre de recherches en cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, Jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille, France. Electronic address:

View Article and Find Full Text PDF
April 2017

Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France.

Med Decis Making 2017 07 15;37(5):555-566. Epub 2017 Feb 15.

Institut Paoli Calmettes, Department of Molecular Oncology, and CRCM, Inserm, U1068; Aix-Marseille Université, UM 105; CNRS, UMR7258, F-13009, Marseille, France (AG, PV).

View Article and Find Full Text PDF
July 2017

Bevacizumab in HER2-negative inflammatory breast cancer.

Oncoscience 2016 15;3(11-12):297-298. Epub 2016 Nov 15.

Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.

View Article and Find Full Text PDF
November 2016

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

J Cancer 2016 23;7(14):2077-2084. Epub 2016 Oct 23.

Aix-Marseille Université, Marseille, F-13284, France.; Centre de Thérapie Cellulaire, Département de Biologie du Cancer, Institut Paoli-Calmettes, Marseille, F-13273, France.; Centre d'Investigations Cliniques en Biothérapies, Inserm CBT-1409, Marseille, F-13009, France.

View Article and Find Full Text PDF
October 2016

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

Eur J Cancer 2016 11 24;67:223. Epub 2016 Sep 24.

Département d'Oncologie Médicale, Institut Paoli-Calmettes (IPC), Marseille, F-13273, France; Centre de Recherches en Cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, Marseille, F-13009, France; Aix-Marseille Université, Marseille, F-13284, France. Electronic address:

View Article and Find Full Text PDF
November 2016

SPAG5: the ultimate marker of proliferation in early breast cancer?

Lancet Oncol 2016 07 14;17(7):863-865. Epub 2016 Jun 14.

Centre de Recherche en Cancérologie de Marseille, Laboratoire d'Oncologie Moléculaire, UMR1068 Inserm, UMR725 CNRS, Institut Paoli-Calmettes (IPC); Marseille 13273, France.

View Article and Find Full Text PDF
July 2016

Comparative genomic analysis of primary tumors and metastases in breast cancer.

Oncotarget 2016 May;7(19):27208-19

Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France.

View Article and Find Full Text PDF
May 2016

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

Eur J Cancer 2016 04 23;57:118-26. Epub 2016 Feb 23.

Département d'Oncologie Médicale, Institut Paoli-Calmettes (IPC), Marseille, F-13273, France; Centre de Recherches en Cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, Marseille, F-13009, France; Aix-Marseille Université, Marseille, F-13284, France. Electronic address:

View Article and Find Full Text PDF
April 2016

METRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors.

Anticancer Res 2016 Jan;36(1):293-9

Department of Oncology, Institut Paoli-Calmettes, Marseille, France Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS U7258, Marseille, France Aix-Marseille Université, Marseille, France.

View Article and Find Full Text PDF
January 2016

Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.

PLoS One 2015 11;10(5):e0123768. Epub 2015 May 11.

CRCM, Team Cell Polarity, Cell signalling and Cancer "Equipe labellisée Ligue Contre le Cancer", Inserm, U1068, Marseille, F-13009, France; Institut Paoli-Calmettes, Marseille, F-13009, France; Aix-Marseille Université, Marseille, F-13284, France; CNRS, UMR7258, F-13009, Marseille, France; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
February 2016

Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.

Int J Gynecol Cancer 2015 Jun;25(5):815-22

*Department of Medical Oncology, Institut Paoli-Calmettes; †Department of Molecular Oncology, INSERM U1068, CNRS U7258, Centre de Recherche en Cancérologie de Marseille; ‡Aix-Marseille University; and §Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
June 2015

Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma.

Am J Pathol 2015 Apr 9;185(4):1022-32. Epub 2015 Mar 9.

Cancer Research Center of Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille University and Paoli-Calmettes Institute, Scientific and Technological Park of Luminy, Marseille, France. Electronic address:

View Article and Find Full Text PDF
April 2015

Prognostic and predictive value of PDL1 expression in breast cancer.

Oncotarget 2015 Mar;6(7):5449-64

Département d'Oncologie Moléculaire, "Equipe labellisée Ligue Contre le Cancer", Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France.

View Article and Find Full Text PDF
March 2015

[Systemic treatments of inflammatory breast cancer: an overview].

Bull Cancer 2014 Dec;101(12):1080-8

Institut Paoli-Calmettes, Oncologie médicale, 232, boulevard Sainte-Marguerite, 13009 Marseille, France, Inserm U1068-CNRS U7258, Aix-Marseille Université, Centre de recherche en cancérologie de Marseille, 13009 Marseille, France, Aix-Marseille Université, 13001 Marseille, France.

View Article and Find Full Text PDF
December 2014

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.

Mol Cancer 2014 Oct 2;13:228. Epub 2014 Oct 2.

Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm, Institut Paoli-Calmettes (IPC), Marseille, France.

View Article and Find Full Text PDF
October 2014

EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer.

Cancer Lett 2014 Dec 10;355(1):70-5. Epub 2014 Sep 10.

Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes (IPC), UMR1068 Inserm, 13009 Marseille, France.

View Article and Find Full Text PDF
December 2014

Genomic profiling of inflammatory breast cancer: a review.

Breast 2014 Oct 4;23(5):538-45. Epub 2014 Jul 4.

Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address:

View Article and Find Full Text PDF
October 2014

Carcinomatous myelitis and meningitis after a squamous cell carcinoma of the lip.

Case Rep Oncol 2014 Jan 16;7(1):33-8. Epub 2014 Jan 16.

Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France ; Department of Molecular Oncology, INSERM U1068, Centre de Recherche en Cancérologie de Marseille, Marseille, France ; CNRS UMR7258, CRCM, Marseille, France ; University of Aix-Marseille, Marseille, France.

View Article and Find Full Text PDF
January 2014

Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer.

PLoS One 2013 18;8(12):e81677. Epub 2013 Dec 18.

U912 (SESSTIM), INSERM, Marseille, France ; Université Aix Marseille, IRD, UMR-S912, Marseille, France ; Service Biostatistique et Technologies de l'Information et de la Communication, Hôpital de la Timone, Assistance Publique - Hopitaux de Marseille, Marseille, France.

View Article and Find Full Text PDF
October 2014

Assessment of prognostic scores in brain metastases from breast cancer.

Neuro Oncol 2014 Mar 4;16(3):421-8. Epub 2013 Dec 4.

APHM, Timone Hospital, Departement of Neuro-Oncology, Marseille, France (E.T.); L'institut Paoli-Calmettes, Department of Medical Oncology, Marseille, France (E.T., A.G.); APHM, Timone Hospital, Department of Neurosurgery, Marseille, France (P.M.); L'institut Paoli-Calmettes, Department of Biostatistics, Marseille, France (B.E.); UMR911, CRO2, Aix-Marseille Université, Marseille, France (P.M.); L'institut Paoli-Calmettes, Department of Anatomic Pathology, Marseille, France (E.C.-J.); L'institut Paoli-Calmettes, Department of Radiotherapy, Marseille, France (A.T.).

View Article and Find Full Text PDF
March 2014

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

Cancer Res 2013 Dec 18;73(24):7290-300. Epub 2013 Oct 18.

Authors' Affiliations: INSERM, U1068, CRCM, Molecular Oncology, Institut Paoli-Calmettes, Biopathology, Aix-Marseille Univ, UM 105, F-13284, Départements d'Oncologie Médicale, Chirugie oncologique, and Radiologie, Institut Paoli-Calmettes, Marseille; and Plateforme ARN interference PArI, CEA SACLAY, Gif-sur-Yvette, France.

View Article and Find Full Text PDF
December 2013

BetaHCG secretion by a pulmonary adenocarcinoma.

World J Surg Oncol 2013 Sep 14;11:228. Epub 2013 Sep 14.

Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.

View Article and Find Full Text PDF
September 2013

Difference in therapeutic response between basal and nonbasal triple-negative breast cancers.

Oncologist 2013 19;18(9):1060-1. Epub 2013 Aug 19.

Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, UMR1068 Inserm; Marseille, France;

View Article and Find Full Text PDF
September 2014

Young breast cancer patients' involvement in treatment decisions: the major role played by decision-making about surgery.

Psychooncology 2013 Nov 7;22(11):2546-56. Epub 2013 Jun 7.

INSERM, UMR912 'Economics and Social Sciences Applied to Health & Analysis of Medical Information' (SESSTIM), Marseille, France; Aix-Marseille University, UMR_S912, IRD, Marseille, France.

View Article and Find Full Text PDF
November 2013

Recent trends in epidemiology of brain metastases: an overview.

Anticancer Res 2012 Nov;32(11):4655-62

AP-HM, Timone Hospital, Departement of Neuro-oncology and Neuro-surgery, Marseille, France.

View Article and Find Full Text PDF
November 2012

Association of carcinoid tumor and low grade glioma.

World J Surg Oncol 2012 Nov 8;10:236. Epub 2012 Nov 8.

Département d'Oncologie Médicale, Institut Paoli-Calmettes, 232 Boulevard Ste Marguerite, 13009 Marseille, France.

View Article and Find Full Text PDF
November 2012

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

J Exp Clin Cancer Res 2012 Oct 16;31:87. Epub 2012 Oct 16.

Department of Medical Oncology, Institut Paoli-Calmettes, 232 Bd Ste-Marguerite, Marseille 13273, France.

View Article and Find Full Text PDF
October 2012

8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancer.

PLoS One 2012 29;7(5):e37943. Epub 2012 May 29.

Centre de Recherche en Cancérologie de Marseille, Department of Molecular Oncology, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
October 2012

Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?

Eur J Cancer 2012 Sep 29;48(13):1939-46. Epub 2012 Mar 29.

Department of Cancer Genetics, Prevention and Screening, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
September 2012

Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.

Breast Cancer Res Treat 2012 Apr 27;132(3):1035-47. Epub 2011 Jul 27.

Département de Pharmacologie Moléculaire and U891 INSERM, Centre de Recherche En Cancérologie de Marseille, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
April 2012

Kinome expression profiling and prognosis of basal breast cancers.

Mol Cancer 2011 Jul 21;10:86. Epub 2011 Jul 21.

Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, Institut Paoli-Calmettes, 27 bd Leï Roure, 13009 Marseille, France.

View Article and Find Full Text PDF
July 2011

Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.

Anticancer Res 2011 Mar;31(3):1079-86

Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM U891, 232, boulevard Sainte Marguerite, 13009 Marseille, France.

View Article and Find Full Text PDF
March 2011

Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

Eur J Cancer 2011 Jul 8;47(10):1537-45. Epub 2011 Mar 8.

Molecular Oncology Department, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
July 2011

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.

Breast Cancer Res Treat 2011 May 11;127(1):273-81. Epub 2010 Nov 11.

Département d'Oncologie Médicale and U891 INSERM, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, 232 Bd. Ste-Marguerite, 13009 Marseille, France.

View Article and Find Full Text PDF
May 2011

Loss, mutation and deregulation of L3MBTL4 in breast cancers.

Mol Cancer 2010 Aug 10;9:213. Epub 2010 Aug 10.

Marseille Cancer Research Center, Department of Molecular Oncology, UMR891 Inserm, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
August 2010

Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies: the French experience.

Cancer 2010 Jun;116(11 Suppl):2829-36

Department of Medical Oncology, Paoli-Calmettes Institute, Marseille Cancer Research Center, UMR891 Inserm, IFR137, Marseille, France.

View Article and Find Full Text PDF
June 2010

Gene expression profiling of inflammatory breast cancer.

Cancer 2010 Jun;116(11 Suppl):2783-93

Department of Molecular Oncology, Cancer Research Center of Marseille, Paoli-Calmettes Institute, UMR891 Inserm, Marseille, France.

View Article and Find Full Text PDF
June 2010

A gene expression signature identifies two prognostic subgroups of basal breast cancer.

Breast Cancer Res Treat 2011 Apr 21;126(2):407-20. Epub 2010 May 21.

Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF
April 2011

[Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers].

Bull Cancer 2010 Mar;97(3):321-39

Institut Paoli-calmettes, Centre de recherche en cancérologie de Marseille, U891 Inserm, oncologie médicale, Marseille, France.

View Article and Find Full Text PDF
March 2010

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.

Clin Cancer Res 2010 Jan 22;16(1):45-55. Epub 2009 Dec 22.

Department of Molecular Oncology, Institut Paoli-Calmettes/UMR891 Institut National de la Sante et de la Recherche Medicale, Université de la Méditerranée, Marseille Cancer Research Center, Marseille, France.

View Article and Find Full Text PDF
January 2010

Prescribers' attitudes toward elderly breast cancer patients. Discrimination or empathy?

Crit Rev Oncol Hematol 2010 Aug 23;75(2):138-50. Epub 2009 Oct 23.

INSERM, U-912 Economic & Social Sciences, Health Systems & Societies (SE4S), Marseille, F-13273, France.

View Article and Find Full Text PDF
August 2010

Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.

Anticancer Drugs 2009 Nov;20(10):946-52

Oncologie Médicale, Centre de Recherche en Cancérologie de Marseille, INSERM U891, Institut Paoli Calmettes, 232, boulevard Sainte Marguerite, Marseille 13000, France.

View Article and Find Full Text PDF
November 2009